Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden

References

• Norda R, Duberg AS, Sonnerborg A, Olcen P. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990–1992. Scand J Infect Dis 1995;27:449–52.
   PubMed Web of Science ®Google Scholar
• Foberg U, Ekermo B, Widell A, Mathiesen U, Fryden A. Hepatitis C virus transmission, 1988–1991, via blood components from donors subsequently found to be anti-HCV-positive. Scand J Infect Dis 1996;28:21–6.
   PubMed Web of Science ®Google Scholar
• Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, . Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958–65.
   PubMed Web of Science ®Google Scholar
• Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, . Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975–82.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen. Rekommendation för screening av patientgrupper som fått blodtransfusion i Sverige före 1992 (National Board of Health and Welfare. Recommendation for screening of patients who received blood transfusion prior to 1992). Sweden: National Board of Health and Welfare; 2007. Available at: http://www.socialstyrelsen.se/publikationer2007/2007-130-6 (Accessed 20 August 2008).
   Google Scholar
• Engholm A. Smittat blod blev Marias död (Contagious blood caused Maria's death). Göteborgs Posten, 19 May 2007.
   Google Scholar
• Lindh M, Hannoun C. Genotyping of hepatitis C virus by TaqMan real-time PCR. J Clin Virol 2005;34:108–14.
   PubMed Web of Science ®Google Scholar
• Islam S, Antonsson L, Westin J, Lagging M. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol 2005;40:867–72.
   PubMed Web of Science ®Google Scholar
• Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19: 1409–17.
   PubMed Web of Science ®Google Scholar
• Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289–93.
   PubMed Web of Science ®Google Scholar
• Lidgren M, Hollander A, Weiland O, Jonsson B. Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life. Scand J Gastroenterol 2007;42:867–77.
   PubMed Web of Science ®Google Scholar
• Wahl M, Hermodsson S, Leman J, Lindholm A, Wejstål R, Norkrans G. Prevalence of antibodies against hepatitis B and C among pregnant women and female blood donors in Sweden. Serodiagn Immunother Infect Dis 1994;6:127–9.
   Google Scholar
• Duberg AS, Nordstrom M, Torner A, Reichard O, Strauss R, Janzon R, . Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 2005;41:652–9.
   PubMed Web of Science ®Google Scholar
• Tynell E, Norda R, Shanwell A, Bjorkman A. Long-term survival in transfusion recipients in Sweden, 1993. Transfusion 2001;41:251–5.
   Google Scholar
• Smittskyddsinstitutet. Statistik hepatit C (Swedish Institute for Infectious Disease Control. Hepatitis C statistics). Sweden, 2010: Smittskyddsinstitutet; Available at: http://www.smittskyddsinstitutet.se/statistik/hepatit-c/ (Accessed 17 January 2010).
   Google Scholar
• Davoren A, Dillon AD, Power JP, Donnellan J, Quinn JM, Willis JW, . Outcome of an optional HCV screening program for blood transfusion recipients in Ireland. Transfusion 2002;42:1501–6.
   Google Scholar
• Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825–32.
   PubMed Web of Science ®Google Scholar
• Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991;14:969–74.
   PubMed Web of Science ®Google Scholar
• Gordon SC, Bayati N, Silverman AL. Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology 1998;28:562–7.
   PubMedGoogle Scholar
• Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999;340:1228–33.
   PubMed Web of Science ®Google Scholar
• Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000;32:91–6.
   PubMed Web of Science ®Google Scholar
• Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A, . Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the mpleentation of blood-donor screening. N Engl J Med 1999;341:866–70.
   PubMed Web of Science ®Google Scholar
• Engholm A. En månad efter beskedet var Ingrid död (Ingrid died one month after being informed). Göteborgs Posten, 7 January 2008.
   Google Scholar